OBJECTIVE: We conducted a retrospective cohort study to determine whether laparoscopic adrenalectomy (LA) is a safe and effective therapy for the management of pheochromocytoma, as compared with open adrenalectomy (OA). METHODS: We collected pertinent data on 47 pheochromocytoma resections from 44 patient charts. Perioperative outcomes of 30 LAs were compared with 14 OAs. RESULTS: Median (and standard deviation [SD]) length of postoperative stay was shorter in the laparoscopic group (3.0, SD 3.3 d v. 6.0, SD 1.1 d; p < 0.05), and tumour size was smaller (3.9, SD 2.7 cm v. 5.0, SD 2.9 cm; p < 0.05). No statistically significant differences were found for operative time or rate of postoperative complications. There were no statistically significant between-group differences in intraoperative hypertensive episodes (systolic blood pressure > 180 and/or diastolic blood pressure > 90) or hypotensive episodes (systolic blood pressure < 100 and/or diastolic blood pressure < 60) or in the need for antihypertensive or vasopressive agents. There were no intraoperative complications related to extremes of blood pressure. There were no perioperative mortalities in this series, nor was there an increased risk of recurrent disease with the laparoscopic technique. CONCLUSION: LA is safe and effective for the management of pheochromocytoma.
OBJECTIVE: We conducted a retrospective cohort study to determine whether laparoscopic adrenalectomy (LA) is a safe and effective therapy for the management of pheochromocytoma, as compared with open adrenalectomy (OA). METHODS: We collected pertinent data on 47 pheochromocytoma resections from 44 patient charts. Perioperative outcomes of 30 LAs were compared with 14 OAs. RESULTS: Median (and standard deviation [SD]) length of postoperative stay was shorter in the laparoscopic group (3.0, SD 3.3 d v. 6.0, SD 1.1 d; p < 0.05), and tumour size was smaller (3.9, SD 2.7 cm v. 5.0, SD 2.9 cm; p < 0.05). No statistically significant differences were found for operative time or rate of postoperative complications. There were no statistically significant between-group differences in intraoperative hypertensive episodes (systolic blood pressure > 180 and/or diastolic blood pressure > 90) or hypotensive episodes (systolic blood pressure < 100 and/or diastolic blood pressure < 60) or in the need for antihypertensive or vasopressive agents. There were no intraoperative complications related to extremes of blood pressure. There were no perioperative mortalities in this series, nor was there an increased risk of recurrent disease with the laparoscopic technique. CONCLUSION: LA is safe and effective for the management of pheochromocytoma.
Authors: Dimitrios Stefanidis; Melanie Goldfarb; Kent W Kercher; William W Hope; William Richardson; Robert D Fanelli Journal: Surg Endosc Date: 2013-09-10 Impact factor: 4.584
Authors: Alessandro M Paganini; Andrea Balla; Mario Guerrieri; Giovanni Lezoche; Roberto Campagnacci; Giancarlo D'Ambrosio; Silvia Quaresima; Maria Vittoria Antonica; Emanuele Lezoche Journal: Surg Endosc Date: 2014-04-16 Impact factor: 4.584
Authors: Peter Nau; Sebastian Demyttenaere; Peter Muscarella; Vimal Narula; Jeffrey W Hazey; E Christopher Ellison; W Scott Melvin Journal: Surg Endosc Date: 2010-04-08 Impact factor: 4.584
Authors: Shyamal H Mehta; Rajan Prakash; L Michael Prisant; Carlos M Isales; John C Morgan; Hadyn Williams; Kapil D Sethi Journal: Nat Rev Neurol Date: 2009-06 Impact factor: 42.937